Frederic Moulin
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 6
- Cannabis and Cannabinoid Research 3
- Pharmacogenetics and Drug Metabolism 2
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Donna M. Dambach (3 shared papers)Bárbara A. Andrews (1 shared paper)Robert A. Roth (3 shared papers)Patricia E. Ganey (3 shared papers)Bryan L. Copple (2 shared papers)Umesh Hanumegowda (1 shared paper)Stanley A. Hefta (1 shared paper)Ji Gao (1 shared paper)
- Journals
- American Journal of Physiology-Gastrointestinal and Liver Physiology (1 paper)Blood (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Hepatology (1 paper)Toxicology in Vitro (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Frederic Moulin
12 papers receiving 384 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 150
- Hepatology 69
- Process Chemistry and Technology 11
- Small Animals 21
- Biochemistry 21
Countries citing papers authored by Frederic Moulin
This map shows the geographic impact of Frederic Moulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Moulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Moulin more than expected).
Fields of papers citing papers by Frederic Moulin
This network shows the impact of papers produced by Frederic Moulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Moulin. The network helps show where Frederic Moulin may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederic Moulin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 137 | |
| 2 | 2016 | 50 | |
| 3 | 2003 | 43 | |
| 4 | 2004 | 43 | |
| 5 | 2002 | 35 | |
| 6 | 2001 | 31 | |
| 7 | 1996 | 27 | |
| 8 | 2024 | 13 | |
| 9 | 1995 | 9 | |
| 10 | 2024 | 7 | |
| 11 | 2013 | 3 | |
| 12 | 2009 | 2 | |
| 13 | 2025 | 0 | |
| 14 | 2025 | 0 |
About Frederic Moulin
Frederic Moulin is a scholar working on Pharmacology, Pharmacology, Oncology, Endocrinology, Diabetes and Metabolism and Hepatology, having authored 14 papers that have together received 400 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (6 papers), Diet, Metabolism, and Disease (3 papers), Cannabis and Cannabinoid Research (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Liver physiology and pathology (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Vitamin K Research Studies (1 paper). The work is most often cited by research in Pharmacology (150 citations), Hepatology (69 citations), Process Chemistry and Technology (11 citations), Small Animals (21 citations) and Biochemistry (21 citations). Frederic Moulin has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Donna M. Dambach, Bárbara A. Andrews, Robert A. Roth, Patricia E. Ganey, Bryan L. Copple, Umesh Hanumegowda, Stanley A. Hefta, Ji Gao, Gregory J. Opiteck and Jun-Hsiang Lin. Their work appears in journals such as American Journal of Physiology-Gastrointestinal and Liver Physiology, Blood, Journal of Pharmacology and Experimental Therapeutics, Journal of Hepatology and Toxicology in Vitro.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.